Dogwood Therapeutics, Inc. (DWTX)
Nasdaq: DWTX · Pharmaceutical Preparations · Alpharetta, GA · filing with the SEC since 2020
Who runs Dogwood Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Duncan Gregory Scott
CHIEF EXECUTIVE OFFICER. First filing Dec 2020, latest Mar 6, 2026, 6 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
15 people on the record since 2020
Officerssales are open-market, Oct 27, 2025 to Oct 27, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | Dec 2020 | Mar 6, 2026 | none |
| Walsh Angela | Chief Financial Officer | Dec 2020 | Mar 6, 2026 | none |
| Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Dec 2020 | Mar 6, 2026 | none |
| Grosswald Ralph | SVP OF OPERATIONS | Dec 2020 | Mar 6, 2026 | none |
Directorssales are open-market, Oct 27, 2025 to Oct 27, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ck Life Sciences Intl (Holdings) Inc | director | Oct 2024 | Oct 27, 2026 | none |
| Conjoint Inc. | director | Mar 2025 | Oct 27, 2026 | none |
| Sealbond Ltd | director | Oct 2024 | Oct 27, 2026 | none |
| De La Rosa Abel | director | Dec 2020 | Jun 17, 2026 | none |
| Keefer David R | director | Dec 2020 | Jun 17, 2026 | none |
| Thomas John C | director | Dec 2020 | Jun 17, 2026 | none |
| Whitley Richard James | director | Dec 2020 | Jun 17, 2026 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.